Company profile for Immunorizon

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Immunorizon, previously named ExploreBio1, was founded in late 2017 and is developing conditionally activated Tumor-Restricted T-and NK-Cell Engagers for cancer therapy. The company extends its pipeline and differentiates by using tri-specific constructs with additional tumor-associated antigens and diverse engagers with both T-cells and NK-cells. The company's platform maintains healthy tumor penetration in the human body, en...
Immunorizon, previously named ExploreBio1, was founded in late 2017 and is developing conditionally activated Tumor-Restricted T-and NK-Cell Engagers for cancer therapy. The company extends its pipeline and differentiates by using tri-specific constructs with additional tumor-associated antigens and diverse engagers with both T-cells and NK-cells. The company's platform maintains healthy tumor penetration in the human body, enabling physicians to protect patients' bodies from the harmful effects of toxicity.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Netherlands
Address
Address
Gustav Mahlerplein 102 Toyo lto Building, 20th Floor 1082 MA Amsterdam
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty